TRACON Pharmaceuticals Inc
OTC:TCON

Watchlist Manager
TRACON Pharmaceuticals Inc Logo
TRACON Pharmaceuticals Inc
OTC:TCON
Watchlist
Price: 0.0322 USD Market Closed
Market Cap: 109.8k USD

Operating Margin
TRACON Pharmaceuticals Inc

-42.6%
Current
-2 431%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-42.6%
=
Operating Profit
-5.2m
/
Revenue
12.1m

Operating Margin Across Competitors

No Stocks Found

TRACON Pharmaceuticals Inc
Glance View

Market Cap
109.8k USD
Industry
Biotechnology

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. The company is headquartered in San Diego, California and currently employs 19 full-time employees. The company went IPO on 2015-01-30. The firm is focused on the development and commercialization of targeted therapeutics for cancer. The firm's product pipelines consist of Envafolimab (KN035), Methoxyamine (TRC102), TJ004309 and Bispecific Antibodies. KN035 is a single-domain PD-L1 antibody that is administered by subcutaneous injection without the need for an adjuvant. KN035 is in Phase II of clinical trials. TRC102 is a clinical-stage small molecule inhibitor of the DNA base excision repair pathway, which is a pathway that causes resistance to alkylating and antimetabolite chemotherapeutics. TRC102 is in multiple Phase I and Phase II clinical trials. TJ004309 is a humanized antibody against CD73, an ecto-enzyme expressed on stromal cells and tumors that converts extracellular adenosine monophosphate (AMP) to adenosine, which is an immunosuppressive metabolite adenosine.

TCON Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-42.6%
=
Operating Profit
-5.2m
/
Revenue
12.1m
What is the Operating Margin of TRACON Pharmaceuticals Inc?

Based on TRACON Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of -42.6%.

Back to Top